3E0Q004
Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | Q Cranial Cavity and Brain |
| Approach | 0 Open |
| Device | 0 Antineoplastic |
| Qualifier | 4 Liquid Brachytherapy Radioisotope |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Cranial Cavity and Brain
The cranial cavity and brain are introduced to substances when infection, tumor, or intractable symptoms demand delivery past the blood-brain barrier that oral or intravenous routes cannot cross effectively. Intraventricular or intrathecal-cranial administration of antibiotics treats resistant meningitis or ventriculitis, while chemotherapeutic agents may be instilled directly into the ventricular system for certain central nervous system malignancies. Access is typically obtained through an existing ventricular catheter, reservoir, or shunt, or via a burr hole placed specifically for the procedure, and precise placement is critical given the brain's sensitivity to volume, pressure, and chemical composition. Documentation should note whether an implanted access device such as an Ommaya reservoir was used, since that detail affects both technique and downstream coding of the device component.
Approach: Open
Open in Administration applies when a substance is introduced directly into a surgically exposed operative site, for instance irrigating an open wound or instilling an antibiotic into an exposed body cavity during surgery. It is distinguished from Percutaneous by the site being fully exposed rather than accessed through a needle puncture.
Substance: Antineoplastic
Antineoplastic designates administration of a substance intended to destroy or inhibit malignant cells, encompassing chemotherapy agents given systemically or regionally as part of cancer treatment. It is distinguished from Destructive Agent, which ablates tissue by direct chemical or physical action rather than targeted cytotoxic pharmacology, and from Radioactive Substance, which achieves its effect through ionizing radiation rather than chemical action.
Qualifier: Liquid Brachytherapy Radioisotope
Denotes a liquid radioactive isotope instilled directly into or near a tumor bed or body cavity to deliver localized radiation therapy, a technique known as brachytherapy. This qualifier is specific to the liquid delivery form, distinguishing it from solid seed or other brachytherapy applicators, and reflects a substance administered rather than an external radiation beam.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.